NasdaqCM - Delayed Quote USD

GeoVax Labs, Inc. (GOVXW)

0.0379
-0.0060
(-13.67%)
At close: 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
5,591.4390
3,954.5760
0
81.5260
385.5010
Operating Expense
30,257.8080
29,098.8560
26,742.9390
14,110.0900
19,131.3240
Operating Income
-24,666.3690
-25,144.2800
-26,742.9390
-14,028.5640
-18,745.8230
Net Non Operating Interest Income Expense
166.5540
151.9840
776.1770
7.4390
3.4500
Other Income Expense
--
--
--
--
172.0560
Pretax Income
-24,499.8150
-24,992.2960
-25,966.7620
-14,021.1250
-18,570.3170
Net Income Common Stockholders
-24,499.8150
-24,992.2960
-25,966.7620
-14,021.1250
-18,570.3170
Diluted NI Available to Com Stockholders
-24,499.8150
-24,992.2960
-25,966.7620
-14,021.1250
-18,570.3170
Total Operating Income as Reported
-24,666.3690
-25,144.2800
-26,742.9390
-14,028.5640
-18,745.8230
Total Expenses
30,257.8080
29,098.8560
26,742.9390
14,110.0900
19,131.3240
Net Income from Continuing & Discontinued Operation
-24,499.8150
-24,992.2960
-25,966.7620
-14,021.1250
-18,570.3170
Normalized Income
-24,499.8150
-24,992.2960
-25,966.7620
-14,021.1250
-18,742.3730
Interest Income
187.9290
173.3590
776.1770
7.4390
4.7360
Interest Expense
--
21.3750
0
0
1.2860
Net Interest Income
166.5540
151.9840
776.1770
7.4390
3.4500
EBIT
-24,493.0100
-24,970.9210
-25,966.7620
-14,028.5640
-18,569.0310
EBITDA
-24,400.2970
-24,875.5530
-25,892.5930
-13,972.2800
-18,530.5100
Reconciled Depreciation
92.7130
95.3680
74.1690
56.2840
38.5210
Net Income from Continuing Operation Net Minority Interest
-24,499.8150
-24,992.2960
-25,966.7620
-14,021.1250
-18,570.3170
Total Unusual Items Excluding Goodwill
--
--
--
0
172.0560
Total Unusual Items
--
--
--
0
172.0560
Normalized EBITDA
-24,400.2970
-24,875.5530
-25,892.5930
-13,972.2800
-18,702.5660
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NLSPW NLS Pharmaceutics AG
0.0140
+1.45%
 
CEROW CERo Therapeutics Holdings, Inc.
0.0170
-9.57%
 
TCBWF TC Biopharm (Holdings) Plc
0.0017
-78.75%
 
ESLAW Estrella Immunopharma, Inc.
0.0400
-5.88%
 
SLXNW Silexion Therapeutics Corp
0.0412
-0.24%
 
COEPW Coeptis Therapeutics Holdings, Inc.
0.0316
-1.86%
 
DRMAW Dermata Therapeutics, Inc.
0.0137
0.00%
 
APLMW Apollomics, Inc.
0.0201
+34.00%
 
LIXTW Lixte Biotechnology Holdings, Inc.
0.0259
+0.39%
 
CDTTW Conduit Pharmaceuticals Inc.
0.0089
-5.32%